scispace - formally typeset
A

Antonio Liuzzi

Researcher at Casa Sollievo della Sofferenza

Publications -  116
Citations -  6454

Antonio Liuzzi is an academic researcher from Casa Sollievo della Sofferenza. The author has contributed to research in topics: Acromegaly & Bromocriptine. The author has an hindex of 44, co-authored 116 publications receiving 6170 citations.

Papers
More filters
Journal ArticleDOI

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

Sonja I. Berndt, +385 more
- 01 May 2013 - 
TL;DR: A genome-wide search for loci associated with the upper versus the lower 5th percentiles of body mass index, height and waist-to-hip ratio as well as clinical classes of obesity, including up to 263,407 individuals of European ancestry finds a large overlap in genetic structure and the distribution of variants between traits based on extremes and the general population and little etiological heterogeneity between obesity subgroups.

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

Sonja I. Berndt, +321 more
Journal ArticleDOI

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure.

TL;DR: The study shows that obesity is associated with an impairment of the entire ghrelin system and the observation that gh Relin is further decreased in cases of abnormal energy profit adds new evidence to the relationship between ghrelIn activity and energy balance in obesity.
Journal ArticleDOI

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

TL;DR: A single oral dose of 2–Br–α–ergocryptine (CB154) lowers considerably plasma GH levels in 7 acromegalic patients and lasts about 4–5 hrs.
Journal ArticleDOI

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

TL;DR: Compared to patients with uncomplicated acromegaly, those with hypertension but without abnormalities of glucose tolerance had an increased prevalence of LV hypertrophy, and disease duration, circulating GH, and IGF-I levels were similar in the 2 groups.